АNTIMETASTATIC EFFECT OF B. SUBTILIS IMV B-7724 LECTIN OBSERVED IN LEWIS LUNG CARCINOMA MODEL.

Autor: Fedosova NI; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine, Kyiv 03022, Ukraine. immunomod@ukr.net, Symchych TV; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine, Kyiv 03022, Ukraine. immunomod@ukr.net, Cheremshenko NL; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine, Kyiv 03022, Ukraine. immunomod@ukr.net, Chumak AV; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine, Kyiv 03022, Ukraine. immunomod@ukr.net, Koval EV; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine, Kyiv 03022, Ukraine. immunomod@ukr.net, Karaman ОМ; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine, Kyiv 03022, Ukraine. immunomod@ukr.net, Voyejkova IM; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine, Kyiv 03022, Ukraine. immunomod@ukr.net

Publikováno v: Experimental oncology [Exp Oncol] 2022 Aug; Vol. 44 (2), pp. 155-158.

Functions of tumor-associated macrophages and macrophages residing in remote anatomical niches in Ehrlich carcinoma bearing mice.

Autor: Symchych TV *; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv 03022, Ukraine., Fedosova NI; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv 03022, Ukraine., Chumak AV; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv 03022, Ukraine., Cheremshenko NL; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv 03022, Ukraine., Karaman ОМ; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv 03022, Ukraine., Burlaka АP; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv 03022, Ukraine., Voyeykova IM; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv 03022, Ukraine.

Publikováno v: Experimental oncology [Exp Oncol] 2020 Sep; Vol. 42 (3), pp. 197-203.

Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model.

Autor: Kraśko JA; Laboratory of Immunology, National Cancer Institute, Vilnius, Vilnius LT-08660, Lithuania.; Department of Immunology, State Research Institute Centre for Innovative Medicine, Vilnius, Vilnius LT-08406, Lithuania.; Department of Manufacturing, JSC 'Froceth', Vilnius, Vilnius LT-08217, Lithuania., Žilionytė K; Laboratory of Immunology, National Cancer Institute, Vilnius, Vilnius LT-08660, Lithuania., Darinskas A; Laboratory of Immunology, National Cancer Institute, Vilnius, Vilnius LT-08660, Lithuania.; Department of Manufacturing, JSC 'Froceth', Vilnius, Vilnius LT-08217, Lithuania.; JSC 'Innovita Research', Vilnius, Vilnius LT-06118, Lithuania., Dobrovolskienė N; Laboratory of Immunology, National Cancer Institute, Vilnius, Vilnius LT-08660, Lithuania., Mlynska A; Laboratory of Immunology, National Cancer Institute, Vilnius, Vilnius LT-08660, Lithuania., Riabceva S; Departments of Neurophysiology and Pathology, Institute of Physiology, Minsk, Minsk BY-220072, Republic of Belarus., Zalutsky I; Departments of Neurophysiology and Pathology, Institute of Physiology, Minsk, Minsk BY-220072, Republic of Belarus., Derevyanko M; Departments of Neurophysiology and Pathology, Institute of Physiology, Minsk, Minsk BY-220072, Republic of Belarus., Kulchitsky V; Departments of Neurophysiology and Pathology, Institute of Physiology, Minsk, Minsk BY-220072, Republic of Belarus., Karaman O; Laboratory of Oncoimmunology and Antitumour Vaccine Engineering, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Kyivs'ka 03022, Ukraine., Fedosova N; Laboratory of Oncoimmunology and Antitumour Vaccine Engineering, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Kyivs'ka 03022, Ukraine., Symchych TV; Laboratory of Oncoimmunology and Antitumour Vaccine Engineering, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Kyivs'ka 03022, Ukraine., Didenko G; Laboratory of Oncoimmunology and Antitumour Vaccine Engineering, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Kyivs'ka 03022, Ukraine., Chekhun V; Laboratory of Oncoimmunology and Antitumour Vaccine Engineering, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Kyivs'ka 03022, Ukraine., Strioga M; Laboratory of Immunology, National Cancer Institute, Vilnius, Vilnius LT-08660, Lithuania., Pašukonienė V; Laboratory of Immunology, National Cancer Institute, Vilnius, Vilnius LT-08660, Lithuania.

Publikováno v: Oncology letters [Oncol Lett] 2018 Apr; Vol. 15 (4), pp. 5098-5104. Date of Electronic Publication: 2018 Feb 05.

Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules.

Autor: Symchych TV; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Fedosova NI; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Karaman ОМ; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Yevstratieva LM; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Lisovenko HS; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Voyeykova IM; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Potebnia HP; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine.

Publikováno v: Experimental oncology [Exp Oncol] 2015 Sep; Vol. 37 (3), pp. 197-202.

The anticancer efficiency of the xenogeneic vaccine and the indication for its use.

Autor: Symchych TV; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Fedosova NI; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Karaman OM; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Yevstratieva LM; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Lisovenko HS; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine., Voyejkova IM, Potebnia HP; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine.

Publikováno v: Experimental oncology [Exp Oncol] 2014 Jun; Vol. 36 (2), pp. 79-84.